Metabolic Disorders
Stonefly helped shape the growth of IPLEX™ by presenting clinical news in very human terms.
Our insights into childhood self-esteem and the science of metabolic disorders helped IPLEX erase the six-month head start its competition had in the marketplace. Our physician- and patient-focused marketing reset the standards and encouraged a new round of research in the field.



